Clinical trials
Phase 3 Alzheimer Disease trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
36 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 1 |
| 2025 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 16 |
| Completed | 12 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Suspended | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 6 |
| Pfizer | 6 |
| Biogen | 2 |
| Bristol-Myers Squibb | 2 |
| Eidos Therapeutics, a BridgeBio company | 2 |
| FORUM Pharmaceuticals Inc | 2 |
| GlaxoSmithKline | 2 |
| TauRx Therapeutics Ltd | 2 |
| Alzheon Inc. | 1 |
| AriBio Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 36 |
| Dementia | 11 |
| Cognitive Dysfunction | 5 |
| Amyloid Neuropathies, Familial | 4 |
| Amyloidosis | 4 |
| Brain Diseases | 3 |
| Neurodegenerative Diseases | 3 |
| Cardiomyopathies | 2 |
| Heart Diseases | 2 |
| Central Nervous System Diseases | 1 |
Trials
Showing 1 to 25 of 36. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.